Notify me when TYBOURNE CAPITAL MANAGEMENT (HK) LTD files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| FBRX | Forte Biosciences, Inc. | Common Stock | 9.99% | $8.72M | $4.32M | 1.27M | +97.9% | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 30 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|